Mauritius-based PE firm invests ₹250 crore in Shriji Polymers

Shriji’s product portfolio includes high-density poly ethylene bottles, polypropylene caps–both continuous thread and child resistant–and other speciality plastic products such as derma bottles, tablet applicators, dosing cards and self-administered metered dosing devices.

The company’s manufacturing facilities are located in key markets across India, the US, and China.

The deal signifies the interest of private equity players in this pharma allied industry of packaging, given India’s cost advantage and policy makers’ efforts to boost domestic manufacturing.

The quantum of stake acquired was not detailed.

This is also in line with Prime Minister Narendra Modi’s call for Atmanirbhar Bharat

Prime Minister Modi in May had remarked that self-reliance will prepare the country for tough competition in the global supply chain, and it is important that India wins this competition during the health crisis.